Mazdutide
MELIA
Innovent · Phase 2 · Not yet recruiting · Enrollment 128
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| LNG-IUS plus Mazdutide | Obesity or overweight | n/r | 1 | n/r | n/r |
| LNG-IUS plus Placebo | Obesity or overweight | n/r | 1 | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Mazdutide
Innovent · Phase 2 · Not yet recruiting · Enrollment 128
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| LNG-IUS plus Mazdutide | Obesity or overweight | n/r | 1 | n/r | n/r |
| LNG-IUS plus Placebo | Obesity or overweight | n/r | 1 | n/r | n/r |